Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ajanta Pharma Limited ( (IN:AJANTPHARM) ) has provided an update.
Ajanta Pharma Limited has announced that its Board of Directors will meet on November 3, 2025, to consider the declaration of the first interim dividend for the financial year ending March 31, 2026. The company has set November 10, 2025, as the record date for the dividend payment, pending approval. This decision is part of the company’s ongoing financial management and could impact shareholder returns, reflecting the company’s financial health and commitment to returning value to its investors.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is a pharmaceutical company based in Mumbai, India. The company is involved in the development, manufacturing, and marketing of pharmaceutical products, with a focus on providing healthcare solutions across various therapeutic segments.
Average Trading Volume: 3,187
Technical Sentiment Signal: Sell
Current Market Cap: 306.6B INR
See more data about AJANTPHARM stock on TipRanks’ Stock Analysis page.